Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness - PubMed (original) (raw)
Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness
H K Manji et al. Biol Psychiatry. 2000.
Abstract
Recent neuroimaging studies have demonstrated regional central nervous system volume reductions in mood disorders, findings that are complemented by postmortem observations of cell atrophy and loss. It is thus noteworthy that lithium and valproate have recently been demonstrated to robustly increase the expression of the cytoprotective protein bcl-2 in the central nervous system. Chronic lithium not only exerts neuroprotective effects in several preclinical paradigms but also enhances hippocampal neurogenesis. Valproate robustly promotes neurite outgrowth and activates the ERK mitogen-activated protein kinase pathway, a signaling pathway utilized by many endogenous neurotrophic factors. Consistent with its preclinical neurotrophic/neuroprotective effects, chronic lithium treatment of patients with manic-depressive illness increases brain N-acetylaspartate (a putative marker of neuronal viability and function) levels, an effect that is localized almost exclusively to gray matter. To determine if lithium was producing neuropil increases, quantitative three-dimensional magnetic resonance imaging studies were undertaken, which revealed that chronic lithium significantly increases total gray matter volume in the human brain of patients with manic-depressive illness. Together, these results suggest that a reconceptualization about the optimal long-term treatment of recurrent mood disorders is warranted. Optimal long-term treatment for these severe illnesses may only be achieved by the early use of agents with neurotrophic/neuroprotective effects, irrespective of the primary, symptomatic treatment.
Similar articles
- Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis.
Hao Y, Creson T, Zhang L, Li P, Du F, Yuan P, Gould TD, Manji HK, Chen G. Hao Y, et al. J Neurosci. 2004 Jul 21;24(29):6590-9. doi: 10.1523/JNEUROSCI.5747-03.2004. J Neurosci. 2004. PMID: 15269271 Free PMC article. - The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA, Zhou R, Du J, Moore GJ, Manji HK. Gray NA, et al. J Clin Psychiatry. 2003;64 Suppl 5:3-17. J Clin Psychiatry. 2003. PMID: 12720479 Review. - A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW, Drevets WC, Manji HK. Moore GJ, et al. J Clin Psychiatry. 2009 Apr 21;70(5):699-705. doi: 10.4088/JCP.07m03745. J Clin Psychiatry. 2009. PMID: 19389332 - The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM. Chuang DM. Ann N Y Acad Sci. 2005 Aug;1053:195-204. doi: 10.1196/annals.1344.018. Ann N Y Acad Sci. 2005. PMID: 16179524 Review.
Cited by
- Involvement of the ipsilateral-to-the-pain anterior-superior hypothalamic subunit in chronic cluster headache.
Ferraro S, Nigri A, Bruzzone MG, Medina Carrion JP, Fedeli D, Demichelis G, Chiapparini L, Ciullo G, Gonzalez AA, Proietti Cecchini A, Giani L, Becker B, Leone M. Ferraro S, et al. J Headache Pain. 2024 Jan 11;25(1):7. doi: 10.1186/s10194-023-01711-0. J Headache Pain. 2024. PMID: 38212704 Free PMC article. - Association of reduced serum EGF and leptin levels with the pathophysiology of major depressive disorder: A case-control study.
Sohan M, Qusar MMAS, Shahriar M, Islam SMA, Bhuiyan MA, Islam MR. Sohan M, et al. PLoS One. 2023 Jul 3;18(7):e0288159. doi: 10.1371/journal.pone.0288159. eCollection 2023. PLoS One. 2023. PMID: 37399205 Free PMC article. - Neuroimaging Studies of Brain Structure in Older Adults with Bipolar Disorder: A Review.
Rajashekar N, Blumberg HP, Villa LM. Rajashekar N, et al. J Psychiatr Brain Sci. 2022;7(4):e220006. doi: 10.20900/jpbs.20220006. Epub 2022 Aug 25. J Psychiatr Brain Sci. 2022. PMID: 36092855 Free PMC article. - Treatment-Specific Hippocampal Subfield Volume Changes With Antidepressant Medication or Cognitive-Behavior Therapy in Treatment-Naive Depression.
Tai HH, Cha J, Vedaei F, Dunlop BW, Craighead WE, Mayberg HS, Choi KS. Tai HH, et al. Front Psychiatry. 2021 Dec 24;12:718539. doi: 10.3389/fpsyt.2021.718539. eCollection 2021. Front Psychiatry. 2021. PMID: 35002790 Free PMC article. - Corpus callosum morphology in major mental disorders: a magnetic resonance imaging study.
Piras F, Vecchio D, Kurth F, Piras F, Banaj N, Ciullo V, Luders E, Spalletta G. Piras F, et al. Brain Commun. 2021 May 11;3(2):fcab100. doi: 10.1093/braincomms/fcab100. eCollection 2021. Brain Commun. 2021. PMID: 34095833 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous